New insights into the role of podocytes in proteinuria

Nature Reviews Nephrology

Volumn 5, Issue 8, 2009, Pages 463-468

  Patrakka, Jaakko ^a   Tryggvason, Karl ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR; PHOSPHOLIPASE C; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; UROKINASE RECEPTOR;

CYTOPATHOLOGY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENETIC DISORDER; GENETIC VARIABILITY; GLOMERULUS FILTRATION; HUMAN; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RATING SCALE; REVIEW;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ENDOTHELIUM, VASCULAR; GLOMERULAR BASEMENT MEMBRANE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY GLOMERULUS; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; PODOCYTES; PROTEINURIA; RECEPTOR, NOTCH1; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; TRPC CATION CHANNELS; TYPE C PHOSPHOLIPASES;

EID: 70349330816     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2009.108     Document Type: Review

References (48)

1. Kanwar, Y. S., Linker, A. & Farquhar, M. G. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J. Cell Biol. 86, 688-693 (1980).
2. Rossi, M. et al. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J. 22, 236-245 (2003)
3. Harvey, S. J. et al. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am. J. Pathol. 171, 139-152 (2007).
4. Goldberg, s., Harvey, s. J., Cunningham, J., Tryggvason, K. & Miner, J. H. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane. Nephrol. Dial. Transplant. doi:10.1093/ndt/gfn758.
5. Tryggvason, K., Patrakka, J. & Wartiovaara, J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N. Engl. J. Med. 354, 1387-1401 (2006).
6. Haraldsson, B., Nystrom, J. & Deen, W. M. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 88, 451-487 (2008).
7. Jeansson, M., Bjorck, K., Tenstad, O. & Haraldsson, B. Adriamycin alters glomerular endothelium to induce proteinuria. J. Am. Soc. Nephrol. 20, 114-122 (2009).
8. Jeansson, M. & Haraldsson, B. Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am. J. Physiol. Renal Physiol. 290, F111-F116 (2006)
9. Eremina, V. et al. veGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358, 1129-1136 (2008)
10. eremina, v. et al. Glomerular-specific alterations of veGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707-716 (2003).
11. Hudson, B. G., Tryggvason, K., Sundaramoorthy, M. & Neilson, E. G. Alport's syndrome, Goodpasture's syndrome, and type iv collagen. N. Engl. J. Med. 348, 2543-2556 (2003).
12. Utriainen, A. et al. structurally altered basement membranes and hydrocephalus in a type Xviii collagen deficient mouse line. Hum. Mol. Genet. 13, 2089-2099 (2004).
13. Miner, J. H. Building the glomerulus: a matricentric view. J. Am. Soc. Nephrol. 16, 857-861 (2005).
14. Noakes, P. G. et al. The renal glomerulus of mice lacking s-laminin/laminin β2: nephrosis despite molecular compensation by laminin β1. Nat. Genet. 10, 400-406 (1995).
15. Zenker, M. et al. Human laminin β2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum. Mol. Genet. 13, 2625-2632 (2004). (Pubitemid 39485411)
16. Jarad, G., Cunningham, J., shaw, A. s. & Miner, J. H. Proteinuria precedes podocyte abnormalities inLamb2-/-mice, implicating the glomerular basement membrane as an albumin barrier. J. Clin. Invest. 116, 2272-2279 (2006).
17. Oh, J., reiser, J. & Mundel, P Dynamic (re) organization of the podocyte actin cytoskeleton in the nephrotic syndrome. Pediatr. Nephrol. 19, 130-137 (2004).
18. Kreidberg, J. A. et al. a3(31 integrin has a crucial role in kidney and lung organogenesis. Development 122, 3537-3547 (1996).
19. Sachs, N. et al. Kidney failure in mice lacking the tetraspanin CD151. J. Cell Biol. 175, 33-39 (2006).
20. Pozzi, A. et al. (31 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev. Biol. 316, 288-301 (2008).
21. Kanasaki, K. et al. Integrin (31-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev. Biol. 313, 584-593 (2008).
22. Doi, M. et al. recombinant human laminin-10 (a5(51-y1). Production, purification, and migration-promoting activity on vascular endothelial cells. J. Biol. Chem. 277, 12741-12748 (2002).
23. Dai, C. et al. essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. J. Am. Soc. Nephrol. 17, 2164-2175 (2006)
24. el-Aouni, C. et al. Podocyte-specific deletion of ntegrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. J. Am. Soc. Nephrol. 17, 1334-1344 (2006).
25. Cohen, C. D. et al. Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins. Proc. Natl Acad. Sci. USA 103, 5682-5687 (2006).
26. radice, G. L. et al. Precocious mammary gland development in P-cadherin-deficient mice. J. Cell Biol. 139, 1025-1032 (1997).
27. Huber, T. B. et al. Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise nteraction of CD2AP Fyn, and synaptopodin. J. Clin. Invest. 116, 1337-1345 (2006).
28. Jones, N. et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 440, 818-823 (2006)
29. Verma, R. et al. Nephrin ectodomain engagement results in src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J. Clin. Invest. 116, 1346-1359 (2006).
30. He, B. et al. Association of genetic variants at 3q22 with nephropathy in patients with type 1 diabetes mellitus. Am. J. Hum. Genet. 84, 5-13 (2009).
31. Garg, P, verma, r., Nihalani, D., Johnstone, D. B. & Holzman, L. B. Neph1 cooperates with nephrin to transduce a signal that induces actin polymerization. Mol. Cell. Biol. 27, 8698-8712 (2007).
32. Reiser, J. et al. TrPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat. Genet. 37, 739-744 (2005)
33. Winn, M. P et al. A mutation in the TrPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308, 1801-1804 (2005).
34. Dietrich, A. et al. increased vascular smooth muscle contractility in TrPC6-/-mice. Mol. Cell. Biol. 25, 6980-6989 (2005).
35. Moller, C. C. et al. induction of TrPC6 channel in acquired forms of proteinuric kidney disease. J. Am. Soc. Nephrol. 18, 29-36 (2007).
36. Hinkes, B. et al. Positional cloning uncovers mutations in PLCe1 responsible for a nephrotic syndrome variant that may be reversible. Nat. Genet. 38, 1397-1405 (2006).
37. Wang, H. et al. Phospholipase C epsilon modulates β-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy. Circ. Res. 97, 1305-1313 (2005).
38. Kao, w. H. et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat. Genet. 40, 1185-1192 (2008).
39. Kopp, J. B. et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet. 40, 1175-1184 (2008).
40. Conti, M. A., even-ram, s., Liu, C., Yamada, K. M. & Adelstein, r. s. Defects in cell adhesion and the visceral endoderm following ablation of nonmuscle myosin heavy chain ii-A in mice. J. Biol. Chem. 279, 41263-41266 (2004).
41. Arrondel, C. et al. expression of the nonmuscle myosin heavy chain iiA in the human kidney and screening for MYH9 mutations in epstein and Fechtner syndromes. J. Am. Soc. Nephrol. 13, 65-74 (2002)
42. wei, C. et al. Modification of kidney barrier function by the urokinase receptor. Nat. Med. 14, 55-63 (2008).
43. Niranjan, T. et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat. Med. 14, 290-298 (2008).
44. He, L. et al. Glomerulus-specific mrNA transcripts and proteins identified through kidney expressed sequence tag database analysis. Kidney Int. 71, 889-900 (2007).
45. Patrakka, J. et al. expression and subcellular distribution of novel glomerulus-associated proteins dendrin, ehd3, sh2d4a, plekhh2, and 2310066e14rik. J. Am. Soc. Nephrol. 18, 689-697 (2007).
46. Takemoto, M. et al. Large-scale identification of genes implicated in kidney glomerulus development and function. EMBO J. 25, 1160-1174 (2006).
47. Berthier, C. C. et al. enhanced expression of Janus kinase-signal tranducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes 58, 469-477 (2009).
48. Faul, C. et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat. Med. 14, 931-938 (2008).